STOCK TITAN

IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company operating in Israel and Germany, has announced it will release its second quarter 2023 financial results on Monday, August 14, 2023, before the market opens. The company will host a zoom web conference at 9:00 a.m. ET on the same day to discuss the results and conduct a Q&A session for investors.

Interested parties can register for the zoom call using the provided link. If unable to attend live, a recording of the call will be available on the company's investor relations website within 24 hours after the event.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), una azienda leader nel settore della cannabis medicinale che opera in Israele e Germania, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2023 lunedì 14 agosto 2023, prima dell'apertura del mercato. L'azienda ospiterà una videoconferenza tramite zoom alle 9:00 ET lo stesso giorno per discutere i risultati e condurre una sessione di domande e risposte per gli investitori.

Le parti interessate possono registrarsi per la chiamata zoom utilizzando il link fornito. Se non si riesce a partecipare dal vivo, una registrazione della chiamata sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda entro 24 ore dopo l'evento.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), una empresa líder en cannabis medicinal que opera en Israel y Alemania, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2023 el lunes 14 de agosto de 2023, antes de la apertura del mercado. La empresa llevará a cabo una videoconferencia por zoom a las 9:00 a.m. ET el mismo día para discutir los resultados y realizar una sesión de preguntas y respuestas para los inversionistas.

Las partes interesadas pueden registrarse para la llamada de zoom utilizando el enlace proporcionado. Si no se puede asistir en vivo, se dispondrá de una grabación de la llamada en el sitio web de relaciones con los inversores de la empresa dentro de las 24 horas posteriores al evento.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC)는 이스라엘과 독일에서 운영되는 선도적인 의료용 대마초 회사로, 2023년 8월 14일 월요일 시장 개장 전에 2023년 2분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 9시(ET)에 줌 화상 회의를 열어 결과에 대해 논의하고 투자자들을 위한 질의응답 시간을 가질 것입니다.

관심 있는 분들은 제공된 링크를 통해 줌 호출에 등록할 수 있습니다. 실시간으로 참석할 수 없는 경우, 이벤트 후 24시간 이내에 회사의 투자자 관계 웹사이트에 통화 녹음이 제공될 것입니다.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), une entreprise leader dans le domaine du cannabis médical opérant en Israël et en Allemagne, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2023 le lundi 14 août 2023, avant l'ouverture du marché. L'entreprise tiendra une conférence web sur Zoom à 9h00 (ET) le même jour pour discuter des résultats et organiser une session de questions-réponses pour les investisseurs.

Les parties intéressées peuvent s'inscrire pour l'appel Zoom en utilisant le lien fourni. Si vous ne pouvez pas assister en direct, un enregistrement de l'appel sera disponible sur le site Web des relations investisseurs de l'entreprise dans les 24 heures suivant l'événement.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), ein führendes Unternehmen für medizinisches Cannabis, das in Israel und Deutschland tätig ist, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2023 am Montag, den 14. August 2023, vor der Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 9:00 Uhr ET eine Zoom-Webkonferenz veranstalten, um die Ergebnisse zu erörtern und eine Fragen-und-Antworten-Sitzung für Investoren durchzuführen.

Interessierte Parteien können sich über den bereitgestellten Link für den Zoom-Anruf registrieren. Wenn Sie nicht live teilnehmen können, wird eine Aufnahme des Anrufs innerhalb von 24 Stunden nach der Veranstaltung auf der Unternehmens-Webseite für Anlegerbeziehungen verfügbar sein.

Positive
  • None.
Negative
  • None.

TORONTO and GLIL YAM, Israel, Aug. 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended June 30, 2023, on Monday, August 14, 2023 before the market opens.

IM Cannabis Logo

The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Link for the zoom call: https://us02web.zoom.us/webinar/register/WN_K_uKpL3gQ_KgdI33GaqgpA

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
+972-77-3603504
info@imcannabis.com

Cision View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-second-quarter-2023-financial-results-on-monday-august-14-at-900am-et-301895533.html

SOURCE IM Cannabis Corp.

FAQ

When will IM Cannabis (IMCC) report its Q2 2023 financial results?

IM Cannabis (IMCC) will report its second quarter 2023 financial results on Monday, August 14, 2023, before the market opens.

How can investors participate in IM Cannabis (IMCC) Q2 2023 earnings call?

Investors can participate in IM Cannabis (IMCC) Q2 2023 earnings call by registering for the zoom web conference scheduled for Monday, August 14, 2023, at 9:00 a.m. ET.

Where can I find the recording of IM Cannabis (IMCC) Q2 2023 earnings call if I miss it?

If you miss the live call, a recording of IM Cannabis (IMCC) Q2 2023 earnings call will be available on the company's investor relations website at https://investors.imcannabis.com/ within 24 hours after the call.

IM Cannabis Corp. Common Shares

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Stock Data

4.35M
2.23M
35.84%
6.38%
0.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Tel Aviv